Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1989;74:726-729
© 1989 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DICKE, J. M.
Right arrow Articles by CRANE, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DICKE, J. M.
Right arrow Articles by CRANE, J. P.

Fetal Biometry as a Screening Tool for the Detection of Chromosomally Abnormal Pregnancies

JEFFREY M. DICKE, MD, DIANA L. GRAY, MD, GIULIANA S. SONGSTER, MD and JAMES P. CRANE, MD

From the Genetics Division, Department of Obstetrics and Gynecology, Washington University School of Medicine, Jewish Hospital of St. Louis, St. Louis, Missouri

Abstract

Recent studies suggest that fetal biometry may allow recognition of pregnancies at risk for Down syndrome. Secondtrimester biparietal diameter (BFD)/femur length and observed- to-expected femur length ratios were examined in 48 chromosomally abnormal fetuses and compared with those of a control population composed of both low-risk patients (maternal age less than 35 years) and high-risk patients (maternal age 35 years or more). Biparietal diameter/femur length ratio correctly identified 18% of Down syndrome pregnancies with a positive predictive value of one in 169 and a false-positive rate of only 4%. When trisomies 21,18, and 13 were considered collectively, a sensitivity of 29% and a predictive value of one in 78 were achieved, with no increase in the false-positive rate (4%). Observed-to-expected femur length ratio was less valuable in detecting chromosomally abnormal fetuses. These data suggest that the BPD/femur length ratio holds promise as a screening tool for the antenatal detection of fetal chromosomal abnormalities. Although encouraging, extrapolation of these results to other centers is not recommended without independent verification




This article has been cited by other articles:


Home page
Obstet GynecolHome page
B. T. PIERCE, E. G. HANCOCK, C. M. KOVAC, P. G. NAPOLITANO, R. F. HUME Jr, and B. C. CALHOUN
Influence of Gestational Age and Maternal Height on Fetal Femur Length Calculations
Obstet. Gynecol., May 1, 2001; 97(5): 742 - 746.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. Smith-Bindman, W. Hosmer, V. A. Feldstein, J. J. Deeks, and J. D. Goldberg
Second-Trimester Ultrasound to Detect Fetuses With Down Syndrome: A Meta-analysis
JAMA, February 28, 2001; 285(8): 1044 - 1055.
[Abstract] [Full Text] [PDF]


Home page
Journal of Diagnostic Medical SonographyHome page
P. K. Clark, T. L. Hurton, J. Stryker, and B. R. Benacerraf
Antenatal Sonographic Findings in Trisomy 21
Journal of Diagnostic Medical Sonography, November 1, 1992; 8(6): 316 - 319.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Obstetricians and Gynecologists.